Embryonic Stem Cell Treatment for AMD
April 22, 2009
The Times of London reports that a team of British scientists and surgeons at the Institute of Ophthalmology at University College London and Moorfields eye hospital have developed the world’s first stem cell therapy to cure age-related macular degeneration.
The treatment involves replacing a layer of degenerated cells with embryonic stem cells that are essentially replicas of the missing cells. The stem cells are placed on an artificial membrane inserted in the back of the retina.
Once perfected in about six to seven years, the procedure could be performed on an outpatient basis in under an hour.
Pfizer has agreed to provide financial backing for continued research and will manufacture the membranes used in the procedure.
For the complete story, see the report by The Times of London.
Jump down to form below to submit your own comments